“Why did FDA delay the approval of MDMA Therapy?” with Rick Doblin – MDMA THERAPY PODCAST #24
Rick Doblin, legendary founder of MAPS, discusses his views on the recent unexpected decision by the FDA to delay the approval of MDMA-Assisted Therapy for broad clinical use. In this interview, Rick clarifies each point raised against MDMA therapy in the recent controversy, then counters and dispels most of the criticism that was raised against the studies.
“How MDMA Therapy saved a veteran” with Jonathan Lubecky – MDMA THERAPY PODCAST #23
After several suicide attempts, a US veteran found MDMA Assisted Therapy, which he claims not only saved his life but also cured him of PTSD. Listen to Jonathan’s remarkable story.
“What happened at the FDA Expert Panel meeting regarding MDMA Therapy?” with Matthew Baggott – MDMA THERAPY PODCAST #22
Dr. Matthew Baggot (a neuroscientist and expert on both the neurophysiology and phenomenology of MDMA and on the FDA drug approval process) shares a number of very interesting, unique, and nuanced insights about the FDA Expert Panel meeting regarding MDMA-Assisted Therapy.
“MDMA Therapy Training at TheraPsil” with Yasmeen deRosenroll – MDMA THERAPY PODCAST #21
TheraPsil is a Canadian West Coast non-profit, best known for their pioneering work with Psilocybin-Assisted Therapy for end-of-life anxiety, as well as their incredible national advocacy efforts. Recently, TheraPsil added MDMA-Assisted Therapy Training to their roster of offerings. Join us for a conversation with Yasmeen de Rosenroll, TheraPsil’s Director of Training and Operations.
“Rachel Nuwer: History of MDMA″ – MDMA THERAPY PODCAST #20
Rachel Nuwer is a science journalist. Her new book “I Feel Love” is to-date the most comprehensive account of the history of MDMA. Rachel paints numerous stories about various colorful people related to the history of MDMA.
“Pamela Kryskow: And the Psychedelic Re-emergence″ – MDMA THERAPY PODCAST #19
Dr. Pamela Kryskow is a powerful force reshaping the Canadian psychedelic scene. In this episode, she talks about various psychedelic initiatives she helped co-create, including a progressive non-profit Roots to Thrive Psychedelic Assisted Therapy, the Psychedelic Association of Canada, the first Canadian post-graduate certificate in psychedelic therapies, and the largest-ever psilocybin microdosing study with over 33,000 participants.
“Safety: MDMA-Assisted Therapy 101″ with Darek Dawda – MDMA THERAPY PODCAST #18
In this third part of the MDMA-Assisted Therapy series, Dr. Darek Dawda reviews numerous topics related to safety. He argues that, given the nature of this therapy, extra emphasis on safety is of utmost importance, and that some aspects of safety, such as what happens after the dosing sessions, require much more attention than they have received to date. The importance of extended Informed Consent is emphasized.
“MDMA Assisted Therapy 2024” with Rick Doblin – MDMA THERAPY PODCAST #17
Darek Dawda in conversation with Rick Doblin, a legendary visionary who founded MAPS, and who is just about to make one of the most effective known psychotherapies legally available for medical therapeutic use. Rick talks about his journey, the power of MDMA-Assisted Therapy, his thoughts on the future of humankind, and much more.
“Integration: MDMA-Assisted Therapy 101″ with Darek Dawda – MDMA THERAPY PODCAST #16
In this second part of the MDMA-Assisted Therapy series, Dr. Darek Dawda discusses some key concepts related to the process of integration.
“How MDMA-Assisted Therapy reopens critical period for bonding” with Gül Dölen – MDMA THERAPY PODCAST #15
Gül’s work is essential for understanding why MDMA-Assisted Therapy is so capable of helping us learn how to love. In this episode, she explains that the critical window for social bonding can be reopened only if BOTH the drug AND the corrective relational experience are present. Hence, the therapeutic context is key to MDMA’s therapeutic benefit. Gül discusses a host of other ideas essential for understanding MDMA-Assisted Therapy.
Gül is a neuroscientist at Johns Hopkins University. She has published in the most prestigious academic journals, including Neuron, Nature, and Science.
